BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 224641)

  • 1. Primary carcinoma of the liver. A histological study of 52 cases from Denmark.
    Nørredam K
    Acta Pathol Microbiol Scand A; 1979 Jul; 87A(4):227-36. PubMed ID: 224641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary liver cancer in non-cirrhotic liver. Epidemiological study based on autopsies performed in Trieste, Italy and Kurume, Japan.
    Giarelli L; Melato M; Zanconati F; Musse MM; Laurino L; Okuda K; Kojiro M
    J Gastroenterol Hepatol; 1991; 6(3):278-82. PubMed ID: 1655097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
    Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
    Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
    Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
    Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary hepatocarcinoma. Epidemiologic case-control study in the province of Bergamo].
    Colloredo Mels G; Paris B; Bertone V; Angeli G
    Minerva Med; 1986 Mar; 77(9-10):297-306. PubMed ID: 3005920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
    Nair S; Mason A; Eason J; Loss G; Perrillo RP
    Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
    Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of primary hepatic carcinoma].
    Iwamura K
    Z Gastroenterol; 1971; 9(8):570-8. PubMed ID: 4341286
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinicomorphological manifestations of primary liver carcinoma (PLC) in liver cirrhosis.
    Ferlan-Marolt V; Markovic S
    Cancer Detect Prev; 1986; 9(5-6):491-3. PubMed ID: 3022928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
    Kaczynski J
    Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.